Safety and efficacy of a new oral contraceptive containing drospirenone

Lee P. Shulman*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

An oral contraceptive containing ethinyl estradiol and the unique progestin drospirenone provides a new contraceptive option. Ethinyl estradiol is the form of synthetic estrogen used in most oral contraceptives. Drospirenone differs from other synthetic progestins in that it is derived from 17 α-spirolactone and is an analogue of spironolactone. The oral contraceptive containing ethinyl estradiol and the unique progestin drospirenone has been shown to be highly efficacious and to provide safety equivalent to that of other oral contraceptive formulations.

Original languageEnglish (US)
Pages (from-to)981-984
Number of pages4
JournalJournal of Reproductive Medicine for the Obstetrician and Gynecologist
Volume47
Issue number11 SUPPL.
StatePublished - Nov 1 2002

Keywords

  • Contraceptives, oral, combined
  • Drospirenone
  • Efficacy
  • Progestins

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Safety and efficacy of a new oral contraceptive containing drospirenone'. Together they form a unique fingerprint.

Cite this